Correlation Between Dermata Therapeutics and COSCIENS Biopharma
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and COSCIENS Biopharma, you can compare the effects of market volatilities on Dermata Therapeutics and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and COSCIENS Biopharma.
Diversification Opportunities for Dermata Therapeutics and COSCIENS Biopharma
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dermata and COSCIENS is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and COSCIENS Biopharma go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and COSCIENS Biopharma
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.06 times more return on investment than COSCIENS Biopharma. However, Dermata Therapeutics is 1.06 times more volatile than COSCIENS Biopharma. It trades about 0.06 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.26 per unit of risk. If you would invest 122.00 in Dermata Therapeutics on September 4, 2024 and sell it today you would earn a total of 5.00 from holding Dermata Therapeutics or generate 4.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. COSCIENS Biopharma
Performance |
| Timeline |
| Dermata Therapeutics |
| COSCIENS Biopharma |
Dermata Therapeutics and COSCIENS Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and COSCIENS Biopharma
The main advantage of trading using opposite Dermata Therapeutics and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.| Dermata Therapeutics vs. Candel Therapeutics | Dermata Therapeutics vs. Cingulate Warrants | Dermata Therapeutics vs. Unicycive Therapeutics | Dermata Therapeutics vs. Cardio Diagnostics Holdings |
| COSCIENS Biopharma vs. Candel Therapeutics | COSCIENS Biopharma vs. Cingulate Warrants | COSCIENS Biopharma vs. Unicycive Therapeutics | COSCIENS Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |